PRESS RELEASE published on 01/03/2023 at 14:38, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
PRESS RELEASE published on 01/03/2023 at 14:36, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE published on 01/03/2023 at 14:35, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Micro Focus International plc
PRESS RELEASE published on 01/03/2023 at 14:32, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Devro plc
PRESS RELEASE published on 01/03/2023 at 14:30, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
PRESS RELEASE published on 01/03/2023 at 14:27, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Biffa plc
PRESS RELEASE published on 01/03/2023 at 14:23, 1 year 10 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Published on 11/22/2024 at 18:45, 2 hours 38 minutes ago CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 5 hours 23 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 5 hours 28 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 6 hours 8 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 6 hours 38 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 18:14, 3 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 3 hours 29 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 4 hours 27 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 5 hours 22 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 14 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 2 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 3 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
